Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Improvements in CYP2C9 Genotyping Accuracy Are Needed: A Report of the First Proficiency Testing for Warfarin-related CYP2C9 and VKORC1 Genotyping in China.

Journal of cardiovascular pharmacology - 1 Aug 2015

Lin Guigao, Yi Lang, Zhang Kuo, Sun Yu, Wang Lunan, Zhang Rui, Xie Jiehong, Li Jinming

Abstract excerpt

Warfarin is the most commonly used oral anticoagulant in clinical practice. The cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase complex 1 (VKORC1) genotypes have been confirmed to be associated with warfarin dose requirements. Accurate genotyping results are of particular importance for obtaining reliable genotype-guided warfarin dosing information. This study aims to determine analytic performance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to China

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C9

Share to Hemorrhage

Share to International Normalized Ratio

Share to Single-Blind Method

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 25815675
DOI: 10.1097/FJC.0000000000000254

Genes

VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Improvements in CYP2C9 Genotyping Accuracy Are Needed: A Report of the First Proficiency Testing for Warfarin-related CYP2C9 and VKORC1 Genotyping in China.PMID 25815675Read ↗

Genotype and phenotype concordance for pharmacogenetic tests through proficiency survey testing.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.Semantic proximity Read ↗

A rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding.Semantic proximity Read ↗

Implementation of Cell Samples as Controls in National Proficiency Testing for Clopidogrel Therapy-Related CYP2C19 Genotyping in China: A Novel Approach.Semantic proximity Read ↗

VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance.Semantic proximity Read ↗

Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX: A GeT-RM Collaborative Project.Semantic proximity Read ↗

Genotype and Phenotype Concordance for Pharmacogenetic Tests Through Proficiency Survey Testing.Semantic proximity Read ↗

Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients.Semantic proximity Read ↗

CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database.Semantic proximity Read ↗

Molecular Genetics External Quality Assessment Pilot Scheme for Irinotecan-Related UGT1A1 Genotyping in China.Semantic proximity Read ↗

Investigation of allele and genotype frequencies of CYP2C9, CYP2C19 and VKORC1 in Iran.Semantic proximity Read ↗

Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.